Successful treatment of relapsed anaplastic large cell lymphoma with vinblastine monotherapy and allo-HSCT with reduced intensity conditioning regimen-Reference-Cited by-同舟云学术

Successful treatment of relapsed anaplastic large cell lymphoma with vinblastine monotherapy and allo-HSCT with reduced intensity conditioning regimen

Published:2015-07-06 Issue:4 Volume:57 Page:791-794
ISSN:1328-8067
Container-title:Pediatrics International
language:en
Short-container-title:Pediatr Int

Author:

Miyagaki Satoshi¹,Imamura Toshihiko¹,Okumura Yoshiki¹,Ito Ikuyo¹,Fujiki Atsushi²,Osone Shinya¹,Ishida Hiroyuki¹²,Hosoi Hajime¹

Affiliation:

1. Department of Pediatrics, Graduate School of Medical Science; Kyoto Prefectural University of Medicine; Kyoto

2. Department of Pediatrics; Matsushita Memorial Hospital; Moriguchi Japan

Publisher

Wiley

Subject

Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ped.12643/fullpdf

Reference14 articles.

1. Single-drug vinblastine as salvage treatment for refractory anaplastic large-cell lymphoma: A report from the French society of pediatric oncology;Brugieres;J. Clin. Oncol.,2009

2. Vinblastine in children and adolescents with high risk anaplastic large-cell lymphoma: Results of the randomized ALCL99-vinblastine trial;DeLey;J. Clin. Oncol.,2010

3. Allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning for a child with recurrent anaplastic large cell lymphoma;Ohta;Int. J. Hematol.,2010

4. A case of refractory anaplastic large cell lymphoma with vinblastine dependency;Shinoda;Jpn. J. Pediatr. Hematol.,2011

5. Relapses of childhood anaplastic large-cell lymphoma: Treatment results in series of 41 children - a report from the French Society of Pediatric Oncology;Brugieres;Ann. Oncol.,2000

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refractory Anaplastic Large Cell Lymphoma Rescued by the Combination of the Second-Generation ALK Inhibitor Brigatinib, High-dose Chemotherapy and Allogeneic Stem Cell Transplantation: A Case Report and Review of the Literature;Clinical Hematology International;2023-04-18

2. Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma;Pediatric Transplantation;2018-05-02

3. Crizotinib induces apoptosis and gene expression changes in ALK+ anaplastic large cell lymphoma cell lines; brentuximab synergizes and doxorubicin antagonizes;Pediatric Blood & Cancer;2018-04-26